Excess Body Fatness during Early to Mid-Adulthood and Survival from Colorectal and Breast Cancer: A Pooled Analysis of Five International Cohort Studies

Background: Here, we explore the association between excess weight during early to mid-adulthood and survival in patients diagnosed with breast and colorectal cancer, using a pooled analysis of five cohort studies and study participants from 11 countries. Methods: Participant-level body mass index (BMI) trajectories were estimated by fitting a growth curve model using over 2 million repeated BMI measurements from close to 600,000 cohort participants. Cumulative measures of excess weight were derived. Data from over 23,000 patients with breast and colorectal cancer were subsequently analyzed using time-to-event models for death with the date of diagnosis as start of follow-up. Study-specific results were combined through a random effect meta-analysis. Results: We found a significant dose–response relationship (P trend = 0.013) between the average BMI during early and mid-adulthood and death from breast cancer, with a pooled HR of 1.31 (1.07–1.60) and the time to death shortened by 16% for average BMI above 25 kg/m2 compared with average BMI less than or equal to 22.5 kg/m2, respectively. Similar results were found for categories of cumulative time spent with excess weight. There was no association between excess body fatness during early to mid-adulthood and death in patients with colorectal cancer. Conclusions: Excess body fatness during early to mid-adulthood is associated not only with an increased risk of developing cancer, but also with a lower survival in patients with breast cancer. Impact: Our results emphasize the importance of public health policies aimed at reducing overweight during adulthood and inform future studies on the relationship between excess weight and cancer outcomes.

[1]  A. Renehan,et al.  Obesity and Cancer Treatment Outcomes: Interpreting the Complex Evidence. , 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

[2]  Paolo Vineis,et al.  Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study , 2020, BMC Medicine.

[3]  F. André,et al.  Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study , 2019, PLoS medicine.

[4]  I. Soerjomataram,et al.  Cumulative exposure to premenopausal obesity and risk of postmenopausal cancer: A population‐based study in Icelandic women , 2019, International journal of cancer.

[5]  C. Storlie,et al.  Obesity and survival among a cohort of breast cancer patients is partially mediated by tumor characteristics , 2019, npj Breast Cancer.

[6]  M. Movahed,et al.  Obesity is strongly and independently associated with a higher prevalence of pulmonary embolism. , 2019, Respiratory investigation.

[7]  H. Adami,et al.  Adult Overweight and Survival from Breast and Colorectal Cancer in Swedish Women , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[8]  A. Jemal,et al.  Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. , 2019, The Lancet. Public health.

[9]  M. Buyse,et al.  Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better? , 2018, Journal of the National Cancer Institute.

[10]  Gretchen A. Stevens,et al.  Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults , 2017, Lancet.

[11]  H. Brenner,et al.  Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe , 2017, British Journal of Cancer.

[12]  H. Adami,et al.  Cohort Profile: The Swedish Women's Lifestyle and Health cohort. , 2017, International journal of epidemiology.

[13]  K. Straif,et al.  Body Fatness and Cancer--Viewpoint of the IARC Working Group. , 2016, The New England journal of medicine.

[14]  V. Beral,et al.  Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents , 2016, The Lancet.

[15]  Thomas E Rohan,et al.  Duration of Adulthood Overweight, Obesity, and Cancer Risk in the Women’s Health Initiative: A Longitudinal Study from the United States , 2016, PLoS medicine.

[16]  K. Mills,et al.  Body mass index and colorectal cancer prognosis: a systematic review and meta-analysis , 2016, Techniques in Coloproctology.

[17]  F. Bray,et al.  Overweight duration in older adults and cancer risk: a study of cohorts in Europe and the United States , 2016, European Journal of Epidemiology.

[18]  Isabelle Romieu,et al.  Obesity and cancer: An update of the global impact. , 2016, Cancer epidemiology.

[19]  N. Horowitz,et al.  Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies. , 2015, Gynecologic oncology.

[20]  S. Tsugane,et al.  The JPHC study: design and some findings on the typical Japanese diet. , 2014, Japanese journal of clinical oncology.

[21]  J. Barendregt,et al.  Estimating the risk of cardiovascular disease using an obese-years metric , 2013, BMJ Open.

[22]  Stephen Burgess,et al.  Combining multiple imputation and meta-analysis with individual participant data , 2013, Statistics in medicine.

[23]  A Gasparrini,et al.  Multivariate meta-analysis for non-linear and other multi-parameter associations , 2012, Statistics in medicine.

[24]  Lori Minasian,et al.  The Role of Obesity in Cancer Survival and Recurrence , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[25]  K. Matsuo,et al.  Association between body mass index and the colorectal cancer risk in Japan: pooled analysis of population-based cohort studies in Japan. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  P. Goodwin,et al.  Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Rory Wolfe,et al.  The number of years lived with obesity and the risk of all-cause and cause-specific mortality. , 2011, International journal of epidemiology.

[28]  Constantine Frangakis,et al.  Multiple imputation by chained equations: what is it and how does it work? , 2011, International journal of methods in psychiatric research.

[29]  Xu Xi,et al.  To Be American , 2011, Fourth Genre: Explorations in Nonfiction.

[30]  M. Coory,et al.  Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis , 2010, Breast Cancer Research and Treatment.

[31]  R. Riley,et al.  Meta-analysis of individual participant data: rationale, conduct, and reporting , 2010, BMJ : British Medical Journal.

[32]  B. Henderson,et al.  Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort , 2010, International journal of cancer.

[33]  J. Meyerhardt,et al.  Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  H. Masoudi,et al.  Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. , 2008, Cancer research.

[35]  M. Falagas,et al.  Obesity and infection. , 2006, The Lancet. Infectious diseases.

[36]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[37]  S. Love,et al.  Survival Analysis Part II: Multivariate data analysis – an introduction to concepts and methods , 2003, British Journal of Cancer.

[38]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[39]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[40]  C. Bouchard,et al.  The effect of sex, age and race on estimating percentage body fat from body mass index: The Heritage Family Study , 2002, International Journal of Obesity.

[41]  J. Seidell,et al.  Epidemiology of obesity. , 2002, Seminars in vascular medicine.

[42]  Gretchen A. Stevens,et al.  Global burden of cancer attributable to high body-mass index in 2012: a population-based study. , 2015, The Lancet. Oncology.

[43]  R. Shephard Body-Mass Index and Mortality among 1.46 Million White Adults , 2011 .

[44]  Douglas G Altman,et al.  Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines , 2009, BMC medical research methodology.

[45]  M. Thun,et al.  The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. , 2002, Cancer.

[46]  Lee-Jen Wei,et al.  The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis. , 1992, Statistics in medicine.